| abstract |
MUCOSA TOLERANCE INDUCTING THE ANTIGENS. The present invention relates to mucosal induction of antigen tolerance, preferably by oral administration of the antigen in combination with a microorganism producing an immunomodulatory compound. More specifically, the invention relates to the induction of Foxp3 + + and / or IL-10 and / or TGF-? producing regulatory T cells capable of suppressing unwanted immune responses to an antigen by oral administration of said antigen in combination with a microorganism producing an immunosuppressive cytokine. |